Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.
View Top Employees from Autolus Ltd.| Website | http://www.autolus.com |
| Ticker | AUTL |
| Revenue | $61 million |
| Employees | 521 (475 on RocketReach) |
| Founded | 2014 |
| Phone | +44 20 3829 6230 |
| Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
| Industry | Biotechnology, Business Services General, Biopharma, Business Services, Health Care, Science and Engineering, Medical, Pharmaceutical |
| Keywords | Cancer Treatment, Solid Tumors |
| Competitors | Achilles Therapeutics plc, Adaptimmune, Mereo BioPharma, Mission Therapeutics, Oxford Biomedica |
| SIC | SIC Code 73 Companies, SIC Code 87 Companies, SIC Code 873 Companies, SIC Code 738 Companies, SIC Code 7389 Companies, SIC Code 8731 Companies |
| NAICS | NAICS Code 54199 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5419 Companies |
Looking for a particular Autolus Ltd. employee's phone or email?
Autolus Ltd. Questions
The Autolus Ltd. annual revenue was $61 million in 2024.
475 people are employed at Autolus Ltd..
The NAICS codes for Autolus Ltd. are [54199, 54, 541, 5419].
The SIC codes for Autolus Ltd. are [73, 87, 873, 738, 7389, 8731].
Top Autolus Ltd. Employees
-
1
-
21
-
35+
-
35
-
21
-
ViewAustin Fisher
Executive Director, CART Patient Support and Distribution at Autolus Ltd.
Scottsdale, AZ, US25+
Related Companies
